Post-traumatic Stress Disorder (PTSD) IQ
Think you know a lot about post-traumatic stress disorder, an anxiety disorder that may occur after one experiences a frightening ordeal? Test your PTSD IQ with our quiz.
According to the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5), posttraumatic stress disorder (PTSD) is a trauma- or stressor-related disorder that can develop after exposure to actual or threatened death, serious injury, or sexual violence. Traumatic events that may trigger PTSD include violent personal assaults, natural or human-caused disasters, such as terrorist attacks, motor vehicle accidents, rape, physical or sexual abuse, severe emotional abuse, or wartime violence, including military combat.
PTSD is a disorder in which your brain continues to react with excessive fear and nervousness after you have experienced or witnessed a trauma or terrifying event, even though the original trauma is over. Our brains can react by staying in overdrive and being hyperalert to the next possible trauma. People with PTSD will re-experience the trauma by having intrusive memories, flashbacks, or nightmares about the event, even though the trauma is in the past. After a traumatic event, we can also become numb and shut down our feelings and try to avoid situations that might cause us to remember the trauma. For other individuals, the effects on emotions and behavior can show up as depression, irritability, or risky behavior.
When you are afraid, your body activates the "fight or flight" response, a response common to other animals as well as our evolutionary ancestors. With this response, the brain activates the sympathetic nervous system, including the release of adrenaline (epinephrine) in the body, which is responsible for increasing blood pressure, heart rate, and increasing glucose to muscles, readying the body for a physical response (fight or flight). However, once the immediate danger (which may or may not have actually existed) is gone, the body begins a process of shutting down the stress response, and this process involves the release of another hormone known as cortisol.
If your body does not generate enough cortisol to shut down the flight or stress reaction, you may continue to feel the stress effects of the adrenaline. Trauma victims who develop post-traumatic stress disorder often have higher levels of other stimulating hormones (catecholamines) under normal conditions in which the threat of trauma is not present as well as lower levels of cortisol. This combination of higher than normal arousal levels and lower than normal levels of the calming hormones of the changes creates the conditions for PTSD.
After a month in this heightened state with stress hormones elevated and cortisol levels lowered, you may develop further physical changes, such as heightened hearing. This cascade of physical changes, one triggering another, suggests that early intervention may be the key to heading off the effects of post-traumatic stress disorder. Not everyone exposed to a trauma has an abnormal reaction, and some who initially experience symptoms find that they resolve in a relatively short period of time. The presence of PTSD symptoms lasting one month or less after a trauma is known as acute stress disorder. Another area of research is to understand why some people are able to recover, while others develop the long-term difficulties of PTSD.
Specific brain regions are also associated with PTSD and the physical responses in the rest of the body. The amygdala is a deep brain region that is highly sensitive to detecting possible threats based on input from our senses. When activated, it alerts the body to danger and activates hormonal systems. The hippocampus is the structure associated with memory formation. Abnormal memory consolidation may also be associated with a risk for PTSD. Some studies showed that a reduction of hippocampus volumes are related to PTSD.
Think you know a lot about post-traumatic stress disorder, an anxiety disorder that may occur after one experiences a frightening ordeal? Test your PTSD IQ with our quiz.
After a trauma in which you think you might die, see someone die, or become seriously injured, and you feel intense fear, helplessness, or horror, it is very common to become distressed and anxious. You may have trouble sleeping, have nightmares, think about the trauma a lot, try to avoid the site of the trauma, and/or try to avoid feelings at all and become more numb. When these symptoms occur shortly after the trauma, and they are severe enough to impair functioning, acute stress disorder is diagnosed. For most people, this distressing period passes within about four weeks. PTSD is diagnosed when these symptoms continue to interfere with daily life and persist more than a month after the initial trauma.
There are four main types of symptoms related to PTSD:
There are also other symptoms and diagnoses often associated with PTSD:
PTSD is often associated with other psychiatric and physical problems.
Children and adolescents also experience trauma and may develop PTSD. Children and teenagers still have the same four categories of symptoms. However, the physical, emotional, and anxiety symptoms of PTSD may be different than those seen in adults.
Following the trauma, children may initially show agitated or confused behavior. They also may show intense fear, helplessness, anger, sadness, horror, or denial. Children who experience repeated trauma may develop a kind of emotional numbing to deaden or block the pain and trauma.
In addition to these core symptoms of PTSD, children may also show the following symptoms:
Research has shown that different types of trauma create different rates of PTSD and that it can change the biochemistry of the brain. The combination of severe trauma, along with previous exposure to trauma creates the highest risk for PTSD. The more severe a trauma, the more likely you are to develop PTSD. If you have already experienced a trauma and you have low cortisol, your brain may be sensitized to trauma and react in a less functional manner to protect you from PTSD. Low levels of cortisol during a trauma may cause you to remember the scary event even more than the average person. Low cortisol may become a marker for those who might develop PTSD after a trauma.
Personal trauma such as rape or sexual abuse leads to a greater risk for PTSD as well. This may be due to the sense of personal betrayal that accompanies these types of traumas. Women suffer from higher rates of PTSD, and rape is thought to be the most likely trauma that may cause a woman to develop PTSD. This may be due to the intense helplessness of a smaller, less strong woman who is assaulted by a male.
People who are prone to PTSD over-respond to cues that resemble danger cues. They also still activate the danger response even as the danger cues decline. We are even learning that PTSD vulnerability can be passed on to the next generation in utero. Studies show that in women who were exposed to 9/11 and developed PTSD while pregnant note that their infants have lower than expected cortisol levels. It is hypothesized that during fetal development, the fetal brain's ability to process cortisol is negatively affected by their mother's hormones.
Major depression as well as chronic daily stress can cause chronically elevated levels of cortisol. The cortisol is constantly produced in an effort to reduce the hyperarousal state of excess flight or flight hormones. People with PTSD cannot mount this high cortisol response and may contribute to some of their symptoms.
PTSD is diagnosed using the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) and requires: exposure to a trauma involving actual or threatened death, serious injury, or sexual violence; persistence of the following symptoms for at least a month; and the symptoms cause significant impairment and are not better explained by another medical or psychiatric condition. Specific diagnostic criteria from the DSM-5 are as follows:
PTSD is a clinical diagnosis; there are no laboratory tests or brain-imaging studies currently used in clinical practice to diagnose PTSD. Brain imaging studies are under way to learn more about the brain in the PTSD condition, but these are not used in everyday medical practice. A physical exam and some blood tests may be necessary to rule out medical conditions that may mimic PTSD, such as hyperthyroidism which can create an anxiety state.
Most people bounce back from traumatic events such as car crashes or assaults, including rape. Short term, most of us would experience some PTSD symptoms. A smaller percentage of people have symptoms that are bad enough to interfere with day-to-day function and are diagnosed with acute stress disorder. Most of these people will also recover within the first month, but a subset of those with ASD will have symptoms lasting longer than a month and are diagnosed with PTSD. We know that some people recover from PTSD at later times -- maybe six months, a year, or even longer. However, some people will have long-term or chronic PTSD symptoms.
At any time after the trauma, if any symptoms are serious enough to affect job performance or the ability to function in day-to-day life, you should consult a licensed mental health professional. Depending on how long the symptoms have cause problems, and which symptoms are worst, different treatments will be appropriate.
Although it may seem painful to remember your trauma, many studies show that avoiding it continues to cause problems. Talking about it with a professional is helpful to many people with PTSD.
As with most psychiatric disorders, there are both psychotherapy and medication (psychopharmacologic) ways of treating PTSD. Either type of treatment can be effective for people with PTSD, but the best type of treatment for an individual should be determined by working with a mental health professional.
The best evidence for psychotherapy treatments of PTSD are for exposure-based therapies, including prolonged exposure therapy (PE), trauma-focused cognitive behavioral therapy (TFCBT), and eye movement desensitization and reprocessing (EMDR). Many other psychotherapy approaches are used by therapists, but there are fewer studies and less evidence about how effective they are. The studies that have been published show that other therapies (non-trauma-focused CBT, psychodynamic psychotherapy, narrative exposure therapy, and others) are more effective than not receiving therapy.
Exposure therapies are based on the principle that people can extinguish a fear response by repeated exposures without negative consequences (a process known as exposure and response prevention). Cognitive behavioral therapies (CBT) involve the identification of dysfunctional/negative thoughts and behaviors, and with structured therapy sessions and between session assignments, work to change them. TFCBT specifically addresses thoughts, fears, and behaviors related to the traumatic event. The theory is that more completely processing the trauma will allow the person to resolve issues around the trauma and reduce PTSD symptoms. EMDR is a specific type of therapy that follows similar principles to TFCBT but specifically pairs a procedure of controlled eye movements linked to processing memories of the trauma. Psychodynamic psychotherapy helps you become more aware of your current feelings and to understand how your past affects the way you feel now. This, in turn, may help in coping with intense feelings from the past trauma.
Most specialists who treat mental health disorders such as depression and anxiety also have experience in treating PTSD, particularly since it is a relatively common disorder. You may find that some professional therapists and counselors (clinical psychologists, clinical social workers, professional counselors) will specialize in trauma-related disorders and have certification with some of the specific therapies, such as EMDR. Medication treatment of PTSD is best managed by psychiatrists who have extensive training in assessing and treating these disorders. Nurse practitioners with certification in psychiatry also have experience with PTSD treatment and work with psychiatrists.
A few medications have been shown to directly reduce the symptoms and distress of PTSD.
The first-line medication treatment for PTSD is the serotonin-specific reuptake inhibitor (SSRI) class of medications. Two SSRIs, sertraline (Zoloft) and paroxetine (Paxil), have been approved by the U.S. Food and Drug Administration (FDA) for the treatment of post-traumatic stress disorder. Most other SSRIs have also been studied and are successfully used in clinical practice for PTSD as well. SSRIs can improve a wide range of PTSD symptoms including re-experiencing, avoidance, hyperarousal, and can improve quality of life. Taking SSRIs for a longer amount of time (36 weeks or more) seems to improve symptoms more. There also seems to be a risk of worsened symptoms if someone stops taking SSRIs after improvement.
Prazosin (Minipres) is an older blood pressure medication that has now been studied extensively for the treatment of PTSD. Prazosin works by blocking some of the effects of the fight or flight nervous system. After initial trials using prazosin to reduce re-experiencing nightmares in combat veterans with PTSD, prazosin has now been shown to be effective for reducing many symptoms of PTSD, regardless of the type of trauma. Prazosin can improve nightmares, sleep time, hyperarousal, and general PTSD symptoms. The U.S. Food and Drug Administration (FDA) has not approved prazosin use for PTSD, but it has been more widely used by psychiatrists in recent years.
For children, there is not as much evidence to support the use of antidepressants, prazosin, or other arousal-dampening medicines (for example, clonidine or propranolol that block some of the effects of adrenaline) as well as for the use of other medications. You should consult a child and adolescent psychiatrist for further information.
In addition to PTSD-specific medications, some people may also require medication to help them with anxiety, depression, addictions, or other psychiatric conditions present along with the PTSD. It is important to have a psychiatrist, or other medical doctor experienced with PTSD, to evaluate which medications would be best and will not interfere with PTSD treatment. For example, the benzodiazepines (including medicines like alprazolam [Xanax], diazepam [Valium], lorazepam [Ativan], and others), a class of medicines used for treating some anxiety, may actually worsen PTSD and make it harder to treat.
Many investigators have tried to learn how PTSD can be prevented after people have experienced traumatic events. The military has tried to collect information on new recruits, including psychological screening, to better understand why some people develop PTSD and others do not. Additionally, other studies are investigating whether laboratory markers, such as low cortisol levels, may help predict who might develop PTSD. We still do not completely understand psychological or laboratory predictors, but hopefully these and other studies will lead to better diagnosis and treatment in the future.
Additionally, there have been studies trying a variety of medications given after a traumatic event to see if they can prevent PTSD. The idea has been that certain medications may be able to lower the intense physiologic arousal right after trauma and prevent the brain from forming traumatic memories. Propranolol, a beta-blocker medication that prevents some of the effects of adrenaline, showed initial promise in research studies, but later studies were not as convincing. Because cortisol levels seem to be lower in PTSD, hydrocortisone (a drug similar to cortisol) was given after a trauma and reduced the rates of PTSD development. In a single study, morphine administered after combat trauma in soldiers during the Iraq war also reduced PTSD rates. Morphine might prevent consolidation of fear memories in the amygdala, but further studies will be needed to prove both how effective it might be and how it works.
Family support, clergy support, psychotherapy, and education about the medical aspects of PTSD are all important in preventing PTSD. Efforts to reduce the frequency of traumatic events, such as child abuse and neglect or sexual trauma, are also important ways that we can reduce rates of PTSD and associated depression and suicide.
The prognosis for PTSD depends upon the severity and length of time a person has suffered from the disorder. The majority of patients with PTSD respond to psychotherapy. There are often residual symptoms, however, and we cannot yet predict who will respond best. Studies have shown in other conditions such as OCD (obsessive compulsive disorder) that psychotherapy can actually change how the brain's chemistry functions. It is reasonable to assume that these changes are possible in PTSD as well.
There are significant risks to a person with PTSD if they do not receive treatment. The symptoms of PTSD are likely to continue to interfere with their function at home, at work, and in their relationships. They may lose their job and/or family due to their irritability, anxiety, or numbness interfering with their ability to love and to work. Suicide is also a risk with untreated PTSD.
National Mental Health Association
2001 N Beauregard Street, 12th Floor
Alexandria, VA 22311
National Institute of Mental Health (NIMH)
Public Information and Communications Branch
6001 Executive Boulevard, Room 8184, MSC 9663
Bethesda, MD 20892-9663
National Center for PTSD
Email: [email protected]
Sidran Institute, Traumatic Stress Education & Advocacy
200 E Joppa Road, Suite 207
Towson, MD 21286
National Institute of Mental Health, Post-Traumatic Stress Disorder (PTSD)
MedlinePlus, Post-Traumatic Stress Disorder
American Psychiatric Association. "Trauma- and Stressor-Related Disorders." In Diagnostic and Statistical Manual of Mental Disorders (5th Ed.). Washington, DC: American Psychiatric Association, 2013.
Bradley, R., J. Greene, et al. "A Multi Dimensional Meta-analysis of Psychotherapy for PTSD." AMJ Psychiatry 162.2 (2005): 214-227.
Bryant, R.A., et al. "A Study of the Protective Function of Acute Morphine Administration on Subsequent Post-Traumatic Stress Disorder." Biological Psychiatry 65.5 Mar. 1, 2009: 438-440.
Campbell, K. "One Year Later: Post-Traumatic Stress Takes Toll on Children." Facts of Life: Issue Briefings for Health Reporters 7.9 Sept. 2002.
Chen, Y.R., K.W. Hung, J.C. Tsai, et al. "Efficacy of eye-movement desensitization and reprocessing for patients with posttraumatic-stress disorder: a meta-analysis of randomized controlled trials." PLoS One 9.8 Aug. 7, 2014: e103676.
Cohen, Beth E., Charles R. Marmar, et al. "Posttraumatic Stress Disorder and Health-Related Quality of Life in Patients With Coronary Heart Disease: Findings From the Heart and Soul Study." Arch Gen Psychiatry 66.11 (2009): 1214-1220.
Cusack, K., D.E. Jonas, C.A. Forneris, et al. "Psychological treatments for adults with posttraumatic stress disorder: A systematic review and meta-analysis." Clin Psychol Rev 43 Feb. 2016: 128-41.
Delahanty, Douglas L., and Nicole R. Nugent. "Predicting PTSD Prospectively Based on Prior Trauma History and Immediate Biological Responses." Annals of the New York Academy of Sciences 1071 July 2006: 27-40. doi: 10.1196/annals.1364.003
Holbrook, T.L., M.R. Galarneau, et al. "Morphine Use After Combat Injury in Iraq and Post-Traumatic Stress Disorder." N Engl J Med 362.2 Jan. 14, 2010: 110-117.
Keane, T.M., Barlow, D.H. Posttraumatic Stress Disorder. In: Barlow DH. Anxiety and its disorders. New York, NY: Guilford Press; 2001.
Kessler, R.C., W.T. Chui, O. Demler, et al. "Prevalence, severity, and comorbdity of 12-months DSM-IV disorders in the National Comorbidity Survey Replication." Arch Gen Psychiatry 62.6 (2005): 617-627.
Lancaster, C.L., J.B. Teeters, D.F. Gros, et al. "Posttraumatic Stress Disorder: Overview of Evidence-Based Assessment and Treatment." J Clin Med 5.11 Nov. 22, 2016: pii: E105.
Langeland, W., and M. Oliff. "Psychobiology of Posttraumatic Stress Disorder in Pediatric Injury Patients: A Review of the Literature." Neurosci Biobehav Rev. 32.1 (2008): 161-174.
Schlenger, W.E., Caddell, J.M., Ebert, L., et al. "Psychological reactions to terrorist attacks: findings from the National Studyof Americans' Reactions to September 11." JAMA 288.5 Aug. 7, 2002: 581-8.
Schuster, M.A., Stein, B.D., Jaycox, L., et al. A national survey of stress reactions after the September 11, 2001, terrorist attacks. N Engl J Med 345.20 Nov. 15, 2001: 1507-12.
Sijbrandij, M., A. Kleiboer, J.I. Bisson, et al. "Pharmacological prevention of post-traumatic stress disorder and acute stress disorder: a systematic review and meta-analysis." Lancet Psychiatry 2.5 May 2015: 413-21.
Singh, B., A.J. Hughes, G. Mehta, et al. "Efficacy of Prazosin in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis." Prim Care Companion CNS Disord 18.4 July 28, 2016.
Yehuda, R., Bierer, L.M. "Transgenerational Transmission of Cortisol and PTSD Risk." Prog Brain Res 167 (2008): 121-135.
Yehuda, R., Halligan, S., Grossman, R. "Childhood trauma and risk for PTSD: Relationship to intergenerational effects of trauma, parental PTSD and cortisol excretion." Stress Dev 13 (2001): 731-751.
What were the symptoms of your PTSD?
What kinds of treatments have been effective for your posttraumatic stress disorder?
Please describe your experience with PTSD.